ROIV - Roivant Sciences Ltd. (ROIV) Q4 2023 Earnings Call Transcript
2024-05-30 12:23:06 ET
Roivant Sciences Ltd. (ROIV)
Q4 2023 Earnings Conference Call
May 30, 2024, 8:00 AM ET
Company Participants
Abby Beier - Principal, Strategic Finance
Matt Gline - Chief Executive Officer
Frank Torti - Managing Director, Vant Chair
Mayukh Sukhatme - President and Chief Investment Officer
Conference Call Participants
David Risinger - Leerink Partners
Louise Chen - Cantor Fitzgerald
Allison Bratzel - Piper Sandler
Corinne Johnson - Goldman Sachs
Brian Cheng - JPMorgan
Yaron Werber - TD Cowen
Yatin Suneja - Guggenheim
Douglas Tsao - H.C. Wainwright
Andy Chen - Wolfe Research
Presentation
Operator
Good day and thank you for standing by. Welcome to the Roivant Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Abby Beier. Please go ahead.
Abby Beier
Good morning and thanks for joining today's call to review Roivant's financial results for the fourth quarter and fiscal year ended March 31, 2024, along with the business update. I'm Abby Beier with Roivant. Presenting today, we have Matt Gline, CEO of Roivant.
For those dialing in via conference call you can find the slides being presented today as well as the press release announcing these updates on our IR website at investor.roivant.com. We'll also be providing the slide numbers as we present to help you follow along. I'd like to remind you that we'll be making certain forward-looking statements during today's presentation.
We strongly encourage you to review the information that we have filed with the SEC along with our Form 10-k for the fiscal year ended March 31, 2024, which we will file after market close today for more information regarding these forward-looking statements and related risks and uncertainties.
And with that, I'll turn it over to Matt.
Matt Gline
Thank you, Abby. Good morning, everybody, and thank you for joining our fiscal year March 31 call. I'm going to start just briefly on Slide 4 with a run for what we're going to talk about and then we'll go through the presentation....
Roivant Sciences Ltd. (ROIV) Q4 2023 Earnings Call Transcript